Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM) for diagnosis and management of bladder outlet obstruction in men: study protocol for a randomised controlled trial

K Bailey, P Abrams, P S Blair, C Chapple, C Glazener, J Horwood, J A Lane, J McGrath, S Noble, R Pickard, G Taylor, G J Young, M J Drake, A L Lewis, K Bailey, P Abrams, P S Blair, C Chapple, C Glazener, J Horwood, J A Lane, J McGrath, S Noble, R Pickard, G Taylor, G J Young, M J Drake, A L Lewis

Abstract

Background: Lower urinary tract symptoms (LUTS) comprise storage symptoms, voiding symptoms and post-voiding symptoms. Prevalence and severity of LUTS increase with age and the progressive increase in the aged population group has emphasised the importance to our society of appropriate and effective management of male LUTS. Identification of causal mechanisms is needed to optimise treatment and uroflowmetry is the simplest non-invasive test of voiding function. Invasive urodynamics can evaluate storage function and voiding function; however, there is currently insufficient evidence to support urodynamics becoming part of routine practice in the clinical evaluation of male LUTS.

Design: A 2-arm trial, set in urology departments of at least 26 National Health Service (NHS) hospitals in the United Kingdom (UK), randomising men with bothersome LUTS for whom surgeons would consider offering surgery, between a care pathway based on urodynamic tests with invasive multichannel cystometry and a care pathway based on non-invasive routine tests. The aim of the trial is to determine whether a care pathway not including invasive urodynamics is no worse for men in terms of symptom outcome than one in which it is included, at 18 months after randomisation. This primary clinical outcome will be measured with the International Prostate Symptom Score (IPSS). We will also establish whether inclusion of invasive urodynamics reduces rates of bladder outlet surgery as a main secondary outcome.

Discussion: The general population has an increased life-expectancy and, as men get older, their prostates enlarge and potentially cause benign prostatic obstruction (BPO) which often requires surgery. Furthermore, voiding symptoms become increasingly prevalent, some of which may not be due to BPO. Therefore, as the population ages, more operations will be considered to relieve BPO, some of which may not actually be appropriate. Hence, there is sustained interest in the diagnostic pathway and this trial could improve the chances of an accurate diagnosis and reduce overall numbers of surgical interventions for BPO in the NHS. The morbidity, and therapy costs, of testing must be weighed against the cost saving of surgery reduction.

Trial registration: Controlled-trials.com - ISRCTN56164274 (confirmed registration: 8 April 2014).

Figures

Fig. 1
Fig. 1
Study flow diagram

References

    1. Jacobsen SJ, Girman CJ, Guess HA, Rhodes T, Oesterling JE, Lieber MM. Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. J Urol. 1996;155(2):595–600. doi: 10.1016/S0022-5347(01)66461-9.
    1. Jones C, Hill J, Chapple C. Management of lower urinary tract symptoms in men: summary of NICE guidance. BMJ. 2010;340:c2354. doi: 10.1136/bmj.c2354.
    1. Abrams PH, Griffiths DJ. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol. 1979;51(2):129–34. doi: 10.1111/j.1464-410X.1979.tb02846.x.
    1. Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int. 1999;84(1):14–5. doi: 10.1046/j.1464-410x.1999.00121.x.
    1. Griffiths CJ, Harding C, Blake C, McIntosh S, Drinnan MJ, Robson WA, et al. A nomogram to classify men with lower urinary tract symptoms using urine flow and noninvasive measurement of bladder pressure. J Urol. 2005;174(4 Pt 1):1323–6. doi: 10.1097/01.ju.0000173637.07357.9e.
    1. Harding CK, Robson W, Drinnan MJ, Griffiths CJ, Ramsden PD, Pickard RS. An automated penile compression release maneuver as a noninvasive test for diagnosis of bladder outlet obstruction. J Urol. 2004;172(6 Pt 1):2312–5. doi: 10.1097/01.ju.0000144027.75838.60.
    1. Aagaard M, Klarskov N, Sonksen J, Bagi P, Colstrup H, Lose G. Urethral pressure reflectometry; a novel technique for simultaneous recording of pressure and cross-sectional area: a study of feasibility in the prostatic urethra. BJU Int. 2012;110(8):1178–83. doi: 10.1111/j.1464-410X.2012.10997.x.
    1. Huang T, Qi J, Yu YJ, Xu D, Jiao Y, Kang J, et al. Predictive value of resistive index, detrusor wall thickness and ultrasound estimated bladder weight regarding the outcome after transurethral prostatectomy for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Int J Urol. 2012;19(4):343–50. doi: 10.1111/j.1442-2042.2011.02942.x.
    1. Park HK, Paick SH, Lho YS, Jun KK, Kim HG. Effect of the ratio of resected tissue in comparison with the prostate transitional zone volume on voiding function improvement after transurethral resection of prostate. Urology. 2012;79(1):202–6. doi: 10.1016/j.urology.2011.07.1397.
    1. Shinbo H, Kurita Y. Application of ultrasonography and the resistive index for evaluating bladder outlet obstruction in patients with benign prostatic hyperplasia. Curr Urol Rep. 2011;12(4):255–60. doi: 10.1007/s11934-011-0189-x.
    1. Ku JH, Ko DW, Cho JY, Oh SJ. Correlation between prostatic urethral angle and bladder outletobstruction index in patients with lower urinary tract symptoms. Urology. 2010;75(6):1467–71. doi: 10.1016/j.urology.2009.08.049.
    1. Parsons BA, Bright E, Shaban AM, Whitehouse A, Drake MJ. The role of invasive and non-invasiveurodynamics in male voiding lower urinary tract symptoms. World J Urol. 2009;2:191-7.
    1. National Clinical Guideline Centre (UK). The Management of Lower Urinary Tract Symptoms in Men [Internet]. London: Royal College of Physicians (UK); 2010. (NICE Clinical Guidelines, No. 97.) Available from:
    1. Lepor H. Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol. 2004;6(Suppl 9):S3–10.
    1. Girman CJ, Jacobsen SJ, Tsukamoto T, Richard F, Garraway WM,, Sagnier PP, et al. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology. 1998;51(3):428–36. doi: 10.1016/S0090-4295(97)00717-6.
    1. Mamoulakis C, Ubbink DT, de la Rosette JJ. Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. Eur Urol. 2009;56(5):798–809. doi: 10.1016/j.eururo.2009.06.037.
    1. Clement KD, Burden H, Warren K, Lapitan MC, Omar MI, Drake MJ. Invasive urodynamic studies for the management of lower urinary tract symptoms (LUTS) in men with voiding dysfunction. Cochrane Database Syst Rev. 2015;4
    1. Oelke M, Burger M, Castro-Diaz D, Chartier-Kastler E, Jimenez Cidre MA, McNicholas T, et al. Diagnosis and medical treatment of lower urinary tract symptoms in adult men: applying specialist guidelines in clinical practice. BJU Int. 2012;110(5):710–8. doi: 10.1111/j.1464-410X.2011.10808.x.
    1. Kristjansson B. A randomised evaluation of routine urodynamics in patients with LUTS [abstract]. Scandinavian. Scand J Urol Nephrol Suppl. 1999;33(Suppl 200):9.
    1. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUAguideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–803. doi: 10.1016/j.juro.2011.01.074.
    1. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol. 2006;50(5):969–80. doi: 10.1016/j.eururo.2005.12.042.
    1. Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn. 2002;21(3):261–74. doi: 10.1002/nau.10066.
    1. Barry MJ, Fowler FJ, Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The AmericanUrological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of theAmerican Urological Association. J Urol. 1992;148(5):1549–57.
    1. Abrams P, Avery K, Gardener N, Donovan J. The International Consultation on Incontinence Modular Questionnaire: . J Urol. 2006;175(3 Pt 1):1063-6.
    1. Glazener C, Boachie C, Buckley B, Cochran C, Dorey G, Grant A, et al. Conservative treatment for urinary incontinence in Men After Prostate Surgery (MAPS): two parallel randomised controlled trials. Health Technol Assess. 2011;15(24):1–290. doi: 10.3310/hta15240.
    1. Edwards PJ, Roberts I, Clarke MJ, Diguiseppi C, Wentz R, Kwan I, et al. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev. 2009;3
    1. Robinson KA, Dennison CR, Wayman DM, Pronovost PJ, Needham DM. Systematic review identifies number of strategies important for retaining study participants. J Clin Epidemiol. 2007;60(8):757–65. doi: 10.1016/j.jclinepi.2006.11.023.
    1. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13. doi: 10.1097/.
    1. Malterud K. The art and science of clinical knowledge: evidence beyond measures and numbers. Lancet. 2001;358(9279):397–400. doi: 10.1016/S0140-6736(01)05548-9.
    1. Britten N. Qualitative interviews in medical research. BMJ. 1995;311(6999):251–3. doi: 10.1136/bmj.311.6999.251.
    1. Glover L, Gannon K, McLoughlin J, Emberton M. Men’s experiences of having lower urinary tract symptoms: factors relating to bother. BJU Int. 2004;94(4):563–7. doi: 10.1111/j.1464-410X.2004.05001.x.
    1. Gannon K, Glover L, O'Neill M, Emberton M. Men and chronic illness: a qualitative study of LUTS. J Health Psychol. 2004;9(3):411–20. doi: 10.1177/1359105304042350.
    1. Wareing M. Lower urinary tract symptoms: a hermeneutic phenomenological study into men’s lived experience. J Clin Nurs. 2005;14(2):239–46. doi: 10.1111/j.1365-2702.2004.01003.x.
    1. Welsh L, Botelho E, Tennstedt S. Race and ethnic differences in health beliefs about lower urinary tract symptoms. Nursing Research. 2011;60(3):165–72. doi: 10.1097/NNR.0b013e3182159cac.
    1. Shaw C, Tansey R, Jackson C, Hyde C, Allan R. Barriers to help seeking in people with urinary symptoms. Fam Pract. 2001;18(1):48–52. doi: 10.1093/fampra/18.1.48.
    1. Coyne KS, Sexton CC, Kopp Z, Chapple CR, Kaplan SA, Aiyer LP, et al. Assessing patients’ descriptions of Lower Urinary Tract Symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research. Int J Clin Pract. 2010;64(9):1260–78. doi: 10.1111/j.1742-1241.2010.02450.x.
    1. Weaver T, Renton A, Tyrer P, Ritchie J. Combining qualitative studies with randomised controlled trials is often useful. BMJ. 1996;313(7057):629. doi: 10.1136/bmj.313.7057.629.
    1. Dicicco-Bloom B, Crabtree BF. The qualitative research interview. Medical education. 2006;40(4):314–21. doi: 10.1111/j.1365-2929.2006.02418.x.
    1. Sandelowski M. Sample size in qualitative research. Research in nursing & health. 1995;18(2):179–83. doi: 10.1002/nur.4770180211.
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3(2):77–101. doi: 10.1191/1478088706qp063oa.
    1. Boyatzis R. Transforming qualitative information: thematic analysis and code development. London: Sage; 1998.
    1. Glaser BG, Strauss AL. The discovery of grounded theory. Chicago: Aldine; 1967.
    1. Charmay K. Constructing grounded theory: a practical guide through qualitative analysis. London: Sage; 2006.
    1. Barry MJ, Cantor A, Roehrborn CG. Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms. J Urol. 2013;189(3):987–92. doi: 10.1016/j.juro.2012.08.257.
    1. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390. doi: 10.1136/bmj.a2390.
    1. The UPSTREAM Trial University of Bristol [cited 2015 02 September]. Available from:.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever